WHAT THE STUDIES FOUND
What Ipamorelin changes and what it hasn't proved
Early tests found a hormone rise. Patients didn't recover sooner, and urine screens used in sports can catch the drug.
What Ipamorelin raises and where the proof stops
In the late nineteen-nineties, Danish researchers made Ipamorelin to release growth hormone from the pea-sized growth gland just below your brain. They hoped to avoid stress reactions, but the later patient trial failed.
The animal results looked unusually neat when I read the papers. The gland responded, while cortisol stayed where it was; cortisol is your main stress hormone.
Most claims made now go far beyond those findings. Ipamorelin never won approval, and it didn't speed recovery after bowel surgery.
Animal work sits behind promises about less fat or more muscle. Our Ipamorelin effects page tells you which claims come from home users and which ones doctors tested.
Sports rules pose a separate concern for you. Testing labs look for Ipamorelin all year because sports groups ban it.
What rose in the blood without a stress surge
In 1998, researchers compared Ipamorelin with GHRP-6, an older growth-hormone drug known for stress reactions [1]. Tests in cells, rats, and pigs showed growth hormone rising without those reactions.
Even when researchers used 200 times the amount that caused the hormone rise, cortisol hardly changed, so the drug avoided the sharp stress response seen with older compounds [1]. Cortisol is the hormone that helps your body handle stress.
Older compounds raised several stress hormones along with growth hormone. Ipamorelin's short protein chain caused less of that unwanted response.
That clean rise is the strongest finding in the record. It tells us what happened soon after one lab dose.
It doesn't tell you whether months of shots build strength. No long human study answered that question.
What the two human studies did and didn't show
One short study in healthy men found a blood peak at 40 minutes [2]. Doctors were timing the drug, not testing strength or better health.
The men's bodies removed half the drug in about 2 hours. That answered a timing question and nothing more.
A Phase 2 trial included 114 adults after bowel surgery [3]. This kind of early trial asks whether a drug helps patients; doctors fed Ipamorelin into a vein and hoped their bowels would work sooner.
Patients given Ipamorelin didn't recover faster than those given a placebo, or dummy treatment. The groups reached the same point in about the same time.
Taken together, the two studies tell you how the body handles one dose and whether the drug helped after surgery, but they don't show stronger muscles, sounder sleep, or safer long-term use. No urgent safety problem appeared during that short hospital stay, yet the drug didn't help the patients recover.
What changed in animals and what no one checked for years
The best-looking sales numbers come from animals. In adult rats, the daily rate of leg-bone growth rose from 42 to 52 microns, or thousandths of a millimeter, without raising IGF-1, a liver-made growth protein, in blood [4].
That was a small bone change in rats, not evidence that your own bones will grow stronger. In 2024, ferrets taking cancer drugs had about 24% less body-weight loss after Ipamorelin [5].
Another test used a similar drug rather than Ipamorelin. Rats given that substance for a month had heart damage that worsened as the amount rose [6].
No one has checked Ipamorelin's effect on the human heart over many months. That missing test leaves the long-term risk unknown.
What sports urine tests can find after a shot
Sports rules are firm about Ipamorelin. The World Anti-Doping Agency bans it during training and contests [7].
A urine screen can pick up very small traces. One lab method picked out Ipamorelin along with 17 other banned growth drugs [9].
Researchers also found which broken pieces of the drug leave in urine over several days [11]. In a separate case, scientists found a chemically changed form in material seized at a border [7].
The border seizure and the urine work answer different questions, so you shouldn't treat one as proof of the other. Our Ipamorelin references page lists the papers behind both findings.